Joseph Tkacz

1.4k total citations
78 papers, 900 citations indexed

About

Joseph Tkacz is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Joseph Tkacz has authored 78 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 20 papers in Physiology and 14 papers in Epidemiology. Recurrent topics in Joseph Tkacz's work include Asthma and respiratory diseases (19 papers), Opioid Use Disorder Treatment (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers). Joseph Tkacz is often cited by papers focused on Asthma and respiratory diseases (19 papers), Opioid Use Disorder Treatment (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers). Joseph Tkacz collaborates with scholars based in United States, Switzerland and United Kingdom. Joseph Tkacz's co-authors include Charles Ruetsch, Catherine L. Davis, John Cacciola, Jamie B. Severt, Yen Chung, Mathew J. Gregoski, Joseph R. Volpicelli, James L. Kreindler, Kate Lambourne and Russell A. Settipane and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Joseph Tkacz

72 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Tkacz United States 18 296 219 206 162 88 78 900
Aaron Yarlas United States 17 123 0.4× 441 2.0× 198 1.0× 306 1.9× 38 0.4× 69 1.2k
Petra Rauchhaus United Kingdom 17 218 0.7× 293 1.3× 86 0.4× 159 1.0× 89 1.0× 37 1.5k
T Dwyer Australia 13 272 0.9× 214 1.0× 50 0.2× 58 0.4× 85 1.0× 27 921
Damla Gökşen Türkiye 19 287 1.0× 152 0.7× 60 0.3× 78 0.5× 194 2.2× 94 1.4k
Duncan Brown United Kingdom 13 140 0.5× 208 0.9× 98 0.5× 209 1.3× 235 2.7× 33 1.1k
Trine Marie Stene Norway 3 134 0.5× 123 0.6× 103 0.5× 58 0.4× 69 0.8× 9 837
Lars Vatten Norway 8 226 0.8× 106 0.5× 211 1.0× 104 0.6× 115 1.3× 10 994
Carla DeMuro United States 16 99 0.3× 98 0.4× 155 0.8× 111 0.7× 114 1.3× 65 1.1k
Petra Jones United Kingdom 3 425 1.4× 212 1.0× 117 0.6× 172 1.1× 497 5.6× 4 1.3k
Christopher F. Bell United States 20 62 0.2× 263 1.2× 48 0.2× 185 1.1× 85 1.0× 65 1.2k

Countries citing papers authored by Joseph Tkacz

Since Specialization
Citations

This map shows the geographic impact of Joseph Tkacz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Tkacz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Tkacz more than expected).

Fields of papers citing papers by Joseph Tkacz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Tkacz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Tkacz. The network helps show where Joseph Tkacz may publish in the future.

Co-authorship network of co-authors of Joseph Tkacz

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Tkacz. A scholar is included among the top collaborators of Joseph Tkacz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Tkacz. Joseph Tkacz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sethi, Sanjay, Hayley D. Germack, Laurence Gozalo, et al.. (2025). Real-World Effectiveness of Budesonide/Glycopyrrolate/Formoterol Fumarate on COPD Exacerbation-Related Healthcare Utilization and Costs: Results from the US Arctos Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A2096–A2096.
2.
Adrish, Muhammad, et al.. (2025). Benralizumab Adherence Reduces Exacerbations and Exacerbation-related Medical Costs Among Patients With Severe Asthma: Results from the Zephyr-5 Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1390–A1390.
3.
4.
5.
6.
7.
Lanz, Miguel J., et al.. (2023). Patterns of rescue and maintenance therapy claims surrounding a clinical encounter for an asthma exacerbation. Annals of Allergy Asthma & Immunology. 131(4). 458–465.e1. 6 indexed citations
8.
Tkacz, Joseph, et al.. (2022). PRIMUS – Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation. Dove Medical Press (Taylor and Francis Group). 23 indexed citations
9.
Goetz, Iris, Casey Choong, David R. Nelson, et al.. (2022). Development of a claims-based flare algorithm for systemic lupus erythematosus. Current Medical Research and Opinion. 38(9). 1641–1649. 3 indexed citations
10.
Lugogo, Njira, et al.. (2021). Real-world patterns and implications of short-acting β2-agonist use in patients with asthma in the United States. Annals of Allergy Asthma & Immunology. 126(6). 681–689.e1. 17 indexed citations
11.
12.
13.
Ruetsch, Charles, et al.. (2017). Heterogeneity of nonadherent buprenorphine patients: subgroup characteristics and outcomes.. PubMed. 23(6). e172–e179. 22 indexed citations
14.
Tkacz, Joseph, et al.. (2016). Relapse In Opioid Use Disorder: Implications For Health Care Utilization And Costs. Value in Health. 19(3). A188–A188. 1 indexed citations
15.
Tkacz, Joseph, et al.. (2016). The Association Between Buprenorphine Medication-Assisted Treatment Adherence And Health Care Service Utilization And Costs. Value in Health. 19(3). A187–A187. 3 indexed citations
16.
Tkacz, Joseph, et al.. (2013). Opioid analgesic-treated chronic pain patients at risk for problematic use.. PubMed. 19(11). 871–80. 12 indexed citations
17.
Ruetsch, Charles, et al.. (2012). The effect of telephonic patient support on treatment for opioid dependence: Outcomes at one year follow-up. Addictive Behaviors. 37(5). 686–689. 20 indexed citations
18.
19.
Tkacz, Joseph, et al.. (2010). Psychiatrist Characteristics That Influence Use of Buprenorphine Medication-Assisted Treatment. Journal of Addiction Medicine. 4(4). 197–203. 20 indexed citations
20.
Davis, Catherine L., et al.. (2006). Aerobic Exercise and Snoring in Overweight Children: A Randomized Controlled Trial. Obesity. 14(11). 1985–1991. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron Yarlas Breakdown of academic impact, for papers by Petra Rauchhaus Breakdown of academic impact, for papers by T Dwyer Breakdown of academic impact, for papers by Damla Gökşen Breakdown of academic impact, for papers by Duncan Brown Breakdown of academic impact, for papers by Trine Marie Stene Breakdown of academic impact, for papers by Lars Vatten Breakdown of academic impact, for papers by Carla DeMuro Breakdown of academic impact, for papers by Petra Jones Breakdown of academic impact, for papers by Christopher F. Bell
Rankless by CCL
2026